Table of Contents
<< Previous Issue | Dec 2022 (Vol: 2022, Issue: 12) | Next Issue >> |
- Section: Licensing
-
Kite Enters into License Agreement with Arcellx for CART-ddBCMA in Multiple Myeloma
-
Novartis Signs License Agreement with MorphoSys to Develop and Commercialise Preclinical Inhibitors for Cancer
-
AbbVie Forms Auto-Immunology Partnership with HotSpot Therapeutics for US$335M
- Section: Mergers & Acquisitions
-
AstraZeneca Bolsters Pipeline with Neogene Therapeutics and C4X Discovery Deals
-
Amgen to Acquire Horizon Therapeutics for US$28.3 B